Insider Selling: Beigene, Ltd. (NASDAQ:ONC) COO Sells 30,654 Shares of Stock

Beigene, Ltd. (NASDAQ:ONC) COO Xiaobin Wu sold 30,654 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $240.74, for a total value of $7,379,643.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Xiaobin Wu also recently made the following trade(s):

• On Thursday, February 20th, Xiaobin Wu sold 21,267 shares of Beigene stock. The shares were sold at an average price of $240.07, for a total value of $5,105,568.69.

Beigene Trading Up 3.2 %

Shares of ONC stock opened at $244.20 on Friday. The company has a quick ratio of 1.72, a current ratio of 1.93 and a debt-to-equity ratio of 0.05. Beigene, Ltd. has a fifty-two week low of $126.97 and a fifty-two week high of $248.16. The company has a market capitalization of $23.90 billion, a price-to-earnings ratio of -29.64, a P/E/G ratio of 9.50 and a beta of 0.63.

Beigene Company Profile

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.